candeltx.com - Bathi operasional EBITDA CADL
Candel Therapeutics (CADL) operations are protected by the humanitarian status of medicine and the stable US ecosystem. The EBITDA trajectory visualizes the actual financial strength of the business, where the 0.00 mark indicates the current state of profit. Growth potential relies on the commercialization of drugs for solid tumors. The CandeVax platform, which utilizes viral vectors for the targeted destruction of cancer cells, provides a competitive advantage.
Candel Therapeutics, Inc. (CADL) - rincian metrik lan laporan keuangan
- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian nilai pasar emiten:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Rasio Total Utang marang Ekuitas Candel Therapeutics|CADL - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Candel Therapeutics Inc.|CADL - Utang perusahaan|Rasio utang marang nilai buku Candel Therapeutics|CADL - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Candel Therapeutics|Likuiditas darurat candeltx.com
- statistik bathi lan rasio pasar:
CADL - Bathi resik perusahaan|Bathi sing dikarepake Candel Therapeutics|CADL - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi Candel Therapeutics Inc.|CADL - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Candel Therapeutics|CADL - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku Candel Therapeutics|CADL - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan candeltx.com|CADL - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Candel Therapeutics
Analisis kabeh metrik perusahaan:Candel Therapeutics - CADL
Future revenues for Candel Therapeutics (CADL) depend on the successful market launch of the CAN-2409 platform oncology drugs for the treatment of brain and prostate cancer. The trend in the company's total operating profit allows for the tracking of real cash flow volumes without quarterly lags, helping investors identify the true business trend and avoid purchasing the asset at a local peak ahead of a potential correction.
Karo sapa Candel Therapeutics saingan
ONC - Bathi operasional sadurunge ngurangi amortisasi|HALO: Bathi operasional sadurunge ngurangi amortisasi|RVMD - Bathi operasional EBITDA|Ascentage Pharma (AAPG) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CG Oncology Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|URGN (UroGen) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Bicara Corp BCAX|Bathi operasional EBITDA PSNL|Bathi operasional sadurunge ngurangi amortisasi erasca.com ERAS|Bathi operasional EBITDA DCTH (Delcath Systems)|Bathi operasional EBITDA Y-mAbs Therapeutics Inc YMAB|AURA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|ARAY (Accuray, Inc.) - Bathi operasional sadurunge amortisasi|SLS: Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi ACTU|CTOR (Citius Oncology) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi TuHURA HURA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Protara (TARA)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi FATE (Fate Pharma)|Aadi Bioscience - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi TCRX|CSBR: Bathi operasional sadurunge ngurangi amortisasi|XBiotech Inc. - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|CVM: Bathi operasional EBITDA|OS Therapies, Inc. - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|RADX (Radiopharm Theranostics) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Artiva ARTV|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Adlai Nortye Ltd. (ANL)|VERU (Veru Inc) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA TPST (Tempest Tx)|Bathi operasional EBITDA Xilio Therapeutics Inc XLO|RENB - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi MURA|KAPA: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi OnKure Therapeutics (OKUR)|Bathi operasional sadurunge ngurangi amortisasi GDTC|Bathi operasional EBITDA Curis Corp|Bathi operasional sadurunge ngurangi amortisasi APLM (Apollomics, Inc.)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi THAR|Bathi operasional EBITDA ADVB (Advanced Biomed)|Pendapatan operasional sadurunge ngurangi amortisasi Genprex Inc. (GNPX)|Calidi Bio - Bathi operasional EBITDA|sunshinebiopharma.com (SBFM) - Bathi operasional sadurunge ngurangi amortisasi|xeneticbio.com (XBIO) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|SLRX - Pendapatan operasional sadurunge ngurangi amortisasi|PPBT (Purple Biotech Ltd.) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi AON (AONC)|Bathi operasional EBITDA BGNE|Bathi operasional EBITDA Checkpoint Therapeutics Inc (CKPT)|Bathi operasional EBITDA ELEV (Elevation Oncology)|ICAD: Bathi operasional sadurunge amortisasi|IKNA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|NTBL: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|VIRX: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi MorphoSys Corporation|NAYA (NAYA Biosciences) - Bathi operasional EBITDA|Bathi operasional EBITDA ascentage.com
